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Does conformal therapy improve dose 
distribution in comparison to old techniques 
in teleradiotherapy of cervical cancer 
patients?
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SUMMARY
BACKGROUND: The use of a combined modality approach – chemotherapy and radiation therapy – in 
the treatment of patients with cervical cancer is associated with signifi cant toxicity, mainly haemato-
logical and gastrointestinal. Conformal radiotherapy has the potential to deliver an adequate dose to 
the target structures while sparing the normal tissue. Both the radiation dose to the small bowel and 
the volume are factors known to infl uence the risk of complications.
AIM: The aim of this study was to determine whether the implementation of conformal modality can 
reduce the volume of normal tissue included in the RT fi eld.
METHODS AND MATERIALS: 14 cervical cancer patients (FIGO IIB and IIIB) treated with conformal 
radiotherapy concurrently with cisplatin (40 mg/m2) administration once a week were analyzed. Ac-
cording to ICRU 50 recommendations target volumes and the organs at risk were contoured on CT 
slices. For the gross tumour volume (GTV) the tumour of the uterus and cervix was traced. The clinical 
target volume (CTV) was defi ned as the vessels and lymph nodes from the obturator level to the aortic 
bifurcation, presacral region, and upper 1/3 of the vagina. The margin for planning target volume 
(PTV) was added. The normal tissue region included the small bowel, large bowel and bladder. Using a 
3D system and multi-leaf collimator a four-fi eld treatment plan was performed for each patient. All 14 
patients were treated with radiotherapy using these conformal 3D plans. Additionally (just for study 
purposes) for each patient we prepared two simpler plans with (1) two-fi eld: anterior-posterior (A-P) 
and posterior-anterior (P-A); and (2) four-fi eld box techniques. Dose-volume histograms of target vol-
umes and organs at risk were calculated for each three plans for every patient and compared. Analysis 
of variance was performed to compute the statistical signifi cance. 
RESULTS: There is no statistical difference between doses received by target volumes – in each plan 
PTV is covered by the 95% isodose. Signifi cantly different volumes of critical organs were included in 
the treatment fi eld, depending on radiotherapy technique (conformal 3D method vs AP–PA two-fi eld 
method): rectum 96.82% vs 38.23%, bowels 61.37% vs 30.79%. 
CONCLUSION: These data suggest that implementation of conformal radiotherapy can reduce the 
irradiated volume in all the contoured critical organs, especially the bowels, compared to old tech-
niques.
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INTRODUCTION
In recent years important changes in the 
treatment of advanced cervical cancer have 
occurred due to implementation of modern 
conformal technologies in radiotherapy and 
addition of chemotherapy (chemoradiothera-
py). The progress in diagnostic imaging (CT, 
MR), including functional imaging (PET, 
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SPET, SPECT) allows us to improve the pre-
cision of defi nition of tumour volume probably 
closer to the real tumour dimensions. Com-
puter systems for dose calculation in tumour 
and healthy tissues integrated with modern 
linacs create room for methods of dynamic 
modulation of the radiation beam which may 
lead to therapeutic index improvement and 
have the potential for progress of treatment 
results. The dose delivered to the cervical 
tumour (GTV) together with the margin of 
potentially infi ltrated tissue (CTV) and phys-
ical margin (PTV) is the sum of tele- and 
brachytherapy doses. The use of conformal 
radiotherapy allows us to deliver a high dose 
to the tumour while limiting the dose to the 
healthy tissues mostly to the bowels, bladder 
and rectum, considered to be critical struc-
tures in cervical cancer radiotherapy. Limit-
ing the volume of healthy tissues seems to be 
especially important in combining radiother-
apy with chemotherapy. Chemotherapy com-
bined with radical radiotherapy is associated 
with higher toxicity. In a meta-analysis of 17 
trials Green et al. [1] found higher haemato-
logical toxicity in radiochemotherapy com-
pared to radiotherapy (8 of 16 trials). The au-
thors also found more early gastrointestinal 
toxicities (G 3–4) in the radiochemotherapy 
group (9% vs. 4%). The rate of late reactions 
in the pelvis did not differ [1, 2, 3].
There is therefore increasing concern over 
adverse radiation effects. In addition, small 
bowel tolerance remains a key barrier to dose-
escalation and potential gains in tumour con-
trol. Ways of minimizing the volume of small 
bowel irradiated are paramount [4].
AIM
The aim of the current analysis was to com-
pare dose distribution in PTV and healthy 
critical organs using three radiotherapy tech-
niques. Two of them were used in the past in 
our institution: 1/ two anterior-posterior op-
posite beams (AP-PA) 2/ the “box” technique 
in various radiotherapy techniques used in the 
past and nowadays. The third, conformal tech-
nique, is currently used.
MATERIAL AND METHODS
We have analyzed accepted treatment plans 
of 14 pts diagnosed with cervical cancer in 
stages IIb-IIIb according to the FIGO clas-
sifi cation. Patients were treated in the Dept. 
of Oncological Gynaecology of the Great Po-
land Cancer Centre from Jan. to April 2005. 
The treatment was conformal teleradiothera-
py with LDR brachytherapy (2 applications) 
together with weekly cisplatin 40 mg/m2. 
Patients were qualifi ed for treatment after 
clinical examination, lab tests, imaging tests 
(USG, CT), and PS assessment (0–2). Patients 
who needed para-aortal node irradiation were 
excluded from this study. Planning and deliv-
ery of radiotherapy was executed according to 
the same principles. After simulation (Varis) 
CT for planning purposes (every 5 mm) was 
performed. 6 patients additionally had MRI 
exams followed by MRI/CT fusion. GTV, CTV 
and PTV were defi ned with CT as well as criti-
cal organs: small and large intestine and uri-
nary bladder. GTV confi ned primary cervical 
tumour, CTV1 was GTV plus 0.5 cm margin 
plus uterine corpus, parametria and 1/3 of the 
vagina; CTV2 (lymph nodes) was the retro-
peritoneal space with lymph nodes along the 
major vessels in the pelvis. PTV was obtained 
by adding a 1.5 cm margin to CTV1 and a 1.0 
cm margin to CTV2. External beam planning 
was done with v. 6.5 (Varian Medical Systems, 
Palo Alto, USA).
For every patient a conformal plan was 
designed using 4 beams encompassing PTV 
(95–107%) with MLC shaping and this plan was 
applied for patients’ treatment. All 14 patients 
were treated using the conformal 3D technique 
described above from Jan. to April 2005. 
Two additional plans for each and every pa-
tient were prepared only for study purposes. 
These two plans were not used for treatment. 
These two “simulation plans” represented 
older, simpler techniques used in our depart-
ment in the past. (1) The fi rst was AP-PA (two 
opposite beams) encompassing the pelvis with 
the tumour. The inferior border was situated 
on the lower edge of the obturator foramina, 
side borders 1.5 cm – 2.0 cm laterally to the 
pelvic bones, upper border to the upper edge 
of the fi fth lumbar vertebra. (2) The second 
“simulation plan” (“box”) was based on 4 op-
posite beams, with borders as described for 
the AP-PA plan except for the anterior border 
situated on the anterior edge of the pubic sym-
physis and the posterior border between the 
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second and third sacral vertebra. The beams 
were modifi ed (enlarged) if the known tumour 
dimensions (acc. to CT) exceeded assumed 
borders.
The dose for all 3 techniques was 50 Gy. 
Dose volume histograms were prepared for 
target volumes and critical organs. Patients 
were treated with 20 MV photons delivered 
with a Varian Clinac 2300CD/S (Varian 
Medical System, Palo Alto, USA). An 80-leaf 
collimator was used for shaping portals. In 
vivo dosimetry was performed for every pa-
tient at the beginning and in the middle of 
radiotherapy course, portal images being 
done every week. In case of change of irradi-
ation parameters (such as signifi cant weight 
loss) patients were re-planned (it occurred 
in 5 pts). These second plans were not con-
sidered in the analysis (the second plan at 
the earliest was prepared after 26 Gy). The 
three-plan comparative analysis was based 
on comparison of mean doses (variance 
analysis) in the target volumes (GTV, CTV, 
PTV) and in critical organs: bladder, small 
intestine, rectum.
RESULTS
The analysis revealed that in every patient 
the PTV was covered by the 95% isodose and 
max. dose did not exceed 107% in the PTV 
as per ICRU criteria. In three patients (28%) 
planned with 3D technique it was necessary 
to broaden the lateral portals (box technique) 
by 1cm-1.5cm in order to avoid geographical 
miss. In Table 1 mean doses Dm (%) (for the 
group of 14 patients) in CTV1, CTV2 and PTV 
using the three techniques, conformal tech-
nique, box technique and AP-PA technique, 
are presented.
In the next table (Table 2) the proportion of 
critical organs receiving the dose prescribed 
for the PTV (50 Gy) are presented (mean % 
values with standard deviation for the group 
of 14 patients). The volume of organs at risk 
differs signifi cantly between analyzed pa-
tients (different capacity), which explains the 
high SD value.
The irradiated volumes (doses) were com-
pared (variance analysis – ANOVA). In the 
table 3a, 3b, and 3c p values for the variance 
test are presented. Techniques were compared 
each to each, e.g. in the table 3a p value for 
the comparison of the rectum volume irradi-
ated with box technique vs. 4 conformal por-
tals is 0.09 – hence the volumes do not differ 
signifi cantly (p=0.09); in the table 3b p value 
for the comparison of small intestine volume 
irradiated with box technique vs. 4 conformal 
portals is 0.039 – hence the volumes differ sig-
nifi cantly (p<0.05).
Table 1. Mean doses Dm (%) in CTV1, CTV2 and PTV with the use of three techniques: conformal technique, 
box technique and AP-PA technique
Table 2. The proportion of critical organs’ volume receiving the dose prescribed for the PTV (50 Gy)
 CTV1 CTV2 PTV
Technique Dm [%] SD Dm [%] SD Dm [%] SD
2 portals AP-PA 102.06 0.77 101.98 0.80 101.93 0.80
box 101.58 0.55 102.01 0.57 102.11 0.52
4 conformal portals 101.60 0.57 101.97 0.55 101.98 0.54
Rectum Small intestine Bladder
Technique V [%] SD V [%] SD V [%] SD
2 portal AP-PA 96.82 9.11 61.37 10.41 97.27 9.71
box 58.59 25.38 48.98 19.88 96.06 12.91
4 conformal portals 38.23 25.72 30.79 16.23 80.64 11.65
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CONCLUSIONS
1. There were no statistically signifi cant dif-
ferences in the mean dose in target volumes 
(CTV1, CTV2, PTV) using the three tech-
niques.
Fig. 1. DVH for bowels in three compared techniques: 
AP-PA (red), box (green), conformal (blue). A signifi cant re-
duction of intestine volume irradiated with conformal and 
box technique is seen compared to AP-PA radiotherapy, 
especially in the dose range 30 Gy – 50 Gy. 
2. There were signifi cant differences 
(p<0.05) in dose distributions in critical or-
gans between the techniques. The smallest 
volumes of critical organs were irradiated 
using the 4-portal conformal technique. The 
greatest volume of rectum and bladder was ir-
radiated using the AP-PA technique.
3. Using a 3D technique allowed us to avoid 
geographical miss in 4 patients.
DISCUSSION
The AP-PA technique was used for many 
years in our institution. The AP-PA technique 
covers the target area with a homogeneous 
dose, but at the expense of considerable risk 
of toxicity for large PTV volumes encompass-
ing critical organs. The risk of complications 
is even higher with combination of radiother-
apy and chemotherapy. The small intestine is 
subject to the greatest toxicity both early and 
late. The total dose (including the dose from 
brachytherapy) and the irradiated volume of 
the intestines contribute to the rates of toxici-
ties. Roesce et al. reported a correlation be-
tween “clinically signifi cant” toxicity and the 
volume of small bowel receiving 90 and 100% 
of the prescription dose – they reported 28% 
incidence of clinically signifi cant acute toxic-
ity [5]. Here we have shown that the simple 
AP-PA technique signifi cantly increases the 
irradiated volumes of rectum, bladder and 
intestine compared to box and 3D conformal 
radiotherapy. The box technique allows the ir-
radiated volumes of critical organs, especially 
bowels, to be reduced, but is associated with 
the risk of geographical miss (in our study 
28%, which correlates with data in the litera-
ture) [6, 7]. Therefore conformal radiotherapy 
seems to be optimal, for it enables 3D defi ni-
tion of the tumour and critical organs and 
then conforming the fi elds with MLC accord-
ing to the PTV shape. For the whole group 
analyzed treatment planning was done using 
CT. Only in 6 patients was MR done addition-
ally with subsequent CT-MR fusion for plan-
ning purposes. MR-based planning was more 
accurate, especially for defi ning the primary 
tumour and infi ltration of the parametria. MR 
should be used for planning wherever possible 
and should be standard in all patients.
Mobility of internal organs in our patients 
is not easy to follow and not even well known 
Table 3. p values for the variance test comparing 
the mean rectum, small intestines and bladder 
volumes irradiated with the dose 50 Gy with three 
different methods (AP-PA, 4 box and 4 conformal)
Rectum
 AP-PA 4 box 4 conformal
AP-PA 0.000 0.000
4 box 0.000 0.090
4 conformal 0.000 0.090
Small intestine
 AP-PA 4 box 4 conformal
AP-PA 0.250 0.000
4 box 0.250 0.039
4 conformal 0.000 0.039
Bladder
 AP-PA 4 box 4 conformal
AP-PA 0.993 0.003
4 box 0.993 0.006
4 conformal 0.003 0.006
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in contrast to e.g. prostate movements.[2] 
PTV was created by adding 1.5 cm to CTV1. 
As Buchali et al.[8] described, the internal 
mobility of the uterine corpus depends on 
bladder and rectum fi lling and ranges from 
3 mm to 15 mm in an up-and-down direction 
and 0 mm to 9 mm in a forward-backward 
direction. Huh et al. have also shown a dif-
ference in uterine volume and angle during 
the whole treatment course (more than 1 cm 
and 30 degrees). In order to get PTV 1 cm 
was added to CTV2. Because of the proximity 
of bone margins it was assumed that the in-
ternal mobility of lymph nodes and vessels is 
lower than the mobility of the uterine corpus 
(L. Van de Bunt et al.)[9].
Another important issue is the day-to-day 
reproducibility of the patient’s position on the 
linac couch for the large fi elds used with no ef-
fi cient immobilization available and frequent 
obesity of the patient. In order to minimize 
this problem these patients require multiple 
verifi cation fi lms and simulation checks – de-
viations of <6 mm for the fi eld position were 
considered acceptable. Nowadays in our cen-
tre “belly boards” are available which enable 
us to minimize the intestine volume irradiat-
ed; however, the belly board does not solve the 
problem of target and critical organ motion [4, 
6, 10, 11]. 
The IMRT technique is hoped to be able to 
minimize critical organ irradiation [1, 2, 12], 
but it was not used in this study. 
Our analysis confi rmed quantitatively that 
conformal planning minimizes the volume of 
irradiated healthy tissues, as it was assumed 
when we introduced this technique into prac-
tice in our institution. The answer to the ques-
tion of what is the impact of statistically sig-
nifi cant minimization of irradiated volume of 
healthy tissues on the rate of radiation side ef-
fects in patients requires longer follow-up and 
a larger group of patients. The results of this 
study encouraged us to implement the IMRT 
technique for gynaecological cancer treat-
ment in a large group of patients, and we are 
waiting for the follow-up results.
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